Resistance to TGFβ suppression and improved anti-tumor responses in CD8+ T cells lacking PTPN22
TGFβ secretion in the tumor microenvironment inhibits T cell-mediated anti-tumor immune responses. Here the authors show that a mutation predisposing to autoimmune diseases confers T cells resistance to TGFβ inhibitory action and could be exploited to engineer immunotherapies for TGFβ secreting tumo...
Guardado en:
Autores principales: | Rebecca J. Brownlie, Celine Garcia, Mate Ravasz, Dietmar Zehn, Robert J. Salmond, Rose Zamoyska |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cdc63d275db74abeb71860f4aa4a1656 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TGFβ suppresses CD8+ T cell expression of CXCR3 and tumor trafficking
por: Andrew J. Gunderson, et al.
Publicado: (2020) -
TRAF3 enhances TCR signaling by regulating the inhibitors Csk and PTPN22
por: Alicia M. Wallis, et al.
Publicado: (2017) -
Recurrence of Graves’ Disease: What Genetics of HLA and PTPN22 Can Tell Us
por: Daniela Vejrazkova, et al.
Publicado: (2021) -
PTPN22 polymorphisms associated with type 1 diabetes mellitus in ethnic populations of Russian Federation
por: O N Ivanova, et al.
Publicado: (2013) -
ASSOCIATION OF CTLA-4 AND PTPN-22 GENES POLYMORPHISMS WITH INCREASED RISK OF AUTOIMMUNE THYROIDITIS IN TATAR POPULATION
por: E. M. Biktagirova, et al.
Publicado: (2014)